We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$13.4B
AUM Growth
+$1.43B
Cap. Flow
+$857M
Cap. Flow %
6.4%
Top 10 Hldgs %
14.37%
Holding
602
New
156
Increased
172
Reduced
106
Closed
146

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$175M
2
LOW icon
Lowe's Companies
LOW
+$167M
3
AZO icon
AutoZone
AZO
+$127M
4
NTRS icon
Northern Trust
NTRS
+$127M
5
MRK icon
Merck
MRK
+$118M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$133M
2
RAI
Reynolds American Inc
RAI
+$126M
3
KEY icon
KeyCorp
KEY
+$113M
4
WMT icon
Walmart Inc
WMT
+$110M
5
OA
Orbital ATK, Inc.
OA
+$108M

Sector Composition

Rank Sector Weight
1 Technology 16.72%
2 Industrials 14.06%
3 Consumer Discretionary 12.07%
4 Healthcare 11.22%
5 Financials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LJPC
601
DELISTED
La Jolla Pharmaceutical Company
LJPC
-80,583
Closed -$2.4M
BHVN
602
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-149,651
Closed -$3.74M

Similar funds

Alyeska Investment Group's Q3 2017 Portfolio in Review

As of Q3 2017, Alyeska Investment Group held 602 positions worth $13.4B, up 12% from $12B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Alyeska Investment Group deployed $857M of net new capital in Q3 2017, opening 156 new positions and adding to 172 existing holdings. Its largest new stake was AutoZone: 238,293 shares worth $142M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $133M trimmed.

  • Alyeska Investment Group's largest Q3 2017 buy was AutoZone: 238,293 shares worth $142M.
  • Alyeska Investment Group added most to Texas Instruments in Q3 2017, an estimated $175M increase.
  • Alyeska Investment Group's biggest Q3 2017 reduction was AbbVie, cutting an estimated $133M.
  • Alyeska Investment Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $126M.
  • Alyeska Investment Group's ten largest holdings make up 14% of its $13.4B portfolio in Q3 2017.
  • Alyeska Investment Group opened 156 new positions and closed 146 in Q3 2017.
  • Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $13.4B.

Based on Alyeska Investment Group's 13F filing for Q3 2017, filed 14 Nov 2017.